Valuation nearly triples to $2.15B six months after a $75M Series C, fueled by unprecedented demand for high-performance inference from hypergrowth AI companies and products. SAN FRANCISCO--(BUSINESS ...
Enveda Biosciences said Thursday it raised $150 million in Series D financing, doubling the cash it’s pulled in from venture capitalists this year to further its drug discovery. Its latest round was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback